Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING.
- DOI
- 10.1016/j.bioactmat.2026.08.026
- Published
- 2027 Jan
- Container
- Bioactive materials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioactmat.2026.08.026,
title = {Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING.},
author = {You W and Gao F and Wang HL and Shen AZ and Zhang Z and Nie X and Huang WQ and Wang LH and You YZ},
year = {2027},
journal = {Bioactive materials},
doi = {10.1016/j.bioactmat.2026.08.026},
url = {https://doi.org/10.1016/j.bioactmat.2026.08.026}
}RIS
TY - JOUR TI - Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING. AU - You W AU - Gao F AU - Wang HL AU - Shen AZ AU - Zhang Z AU - Nie X AU - Huang WQ AU - Wang LH AU - You YZ PY - 2027 JO - Bioactive materials DO - 10.1016/j.bioactmat.2026.08.026 UR - https://doi.org/10.1016/j.bioactmat.2026.08.026 ER -
APA
W, Y., F, G., HL, W., AZ, S., Z, Z., X, N., WQ, H., LH, W., & YZ, Y. (2027). Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING.. Bioactive materials. https://doi.org/10.1016/j.bioactmat.2026.08.026
Source records
- pubmed · retrieved 2026-09-25T23:28:47.816Z